Tisagenlecleucel - The first approved CAR-T-cell therapy: Implications for payers and policy makers

Vinay Prasad

Research output: Contribution to journal › Comment/debate › peer-review

174 Scopus citations

Fingerprint

Dive into the research topics of 'Tisagenlecleucel - The first approved CAR-T-cell therapy: Implications for payers and policy makers'. Together they form a unique fingerprint.